472 related articles for article (PubMed ID: 31971317)
1. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice.
Huang M; Wang Q; Long F; Di Y; Wang J; Zhun Zhu Y; Liu X
FASEB J; 2020 Mar; 34(3):4107-4119. PubMed ID: 31971317
[TBL] [Abstract][Full Text] [Related]
2. BAFF Blockade Attenuates DSS-Induced Chronic Colitis
Zhang Y; Tao M; Chen C; Zhao X; Feng Q; Chen G; Fu Y
Front Immunol; 2022; 13():783254. PubMed ID: 35320937
[TBL] [Abstract][Full Text] [Related]
3. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
[TBL] [Abstract][Full Text] [Related]
4. Dextran sodium sulfate potentiates NLRP3 inflammasome activation by modulating the KCa3.1 potassium channel in a mouse model of colitis.
Zeng B; Huang Y; Chen S; Xu R; Xu L; Qiu J; Shi F; Liu S; Zha Q; Ouyang D; He X
Cell Mol Immunol; 2022 Aug; 19(8):925-943. PubMed ID: 35799057
[TBL] [Abstract][Full Text] [Related]
5. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
6. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome.
Qin M; Long F; Wu W; Yang D; Huang M; Xiao C; Chen X; Liu X; Zhu YZ
Free Radic Biol Med; 2019 Jun; 137():99-109. PubMed ID: 31026586
[TBL] [Abstract][Full Text] [Related]
8. Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway.
Wang K; Lv Q; Miao YM; Qiao SM; Dai Y; Wei ZF
Biochem Pharmacol; 2018 Sep; 155():494-509. PubMed ID: 30071202
[TBL] [Abstract][Full Text] [Related]
9. YAP represses intestinal inflammation through epigenetic silencing of JMJD3.
Zhu H; Lu J; Fu M; Chen P; Yu Y; Chen M; Zhao Q; Wu M; Ye M
Clin Epigenetics; 2024 Jan; 16(1):14. PubMed ID: 38245781
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.
Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V
J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981
[TBL] [Abstract][Full Text] [Related]
11. Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation.
Liu X; Zhou W; Zhang X; Lu P; Du Q; Tao L; Ding Y; Wang Y; Hu R
Biochem Pharmacol; 2016 Jul; 112():37-49. PubMed ID: 27184504
[TBL] [Abstract][Full Text] [Related]
12. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation.
Sun Y; Zhao Y; Yao J; Zhao L; Wu Z; Wang Y; Pan D; Miao H; Guo Q; Lu N
Biochem Pharmacol; 2015 Mar; 94(2):142-54. PubMed ID: 25677765
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
[TBL] [Abstract][Full Text] [Related]
14. Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation.
Mai CT; Wu MM; Wang CL; Su ZR; Cheng YY; Zhang XJ
Mol Immunol; 2019 Jan; 105():76-85. PubMed ID: 30496979
[TBL] [Abstract][Full Text] [Related]
15. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation.
Wang L; Yu Z; Wei C; Zhang L; Song H; Chen B; Yang Q
Oncotarget; 2017 May; 8(20):32937-32945. PubMed ID: 28380426
[TBL] [Abstract][Full Text] [Related]
16. Using Network Pharmacology for Systematic Understanding of Geniposide in Ameliorating Inflammatory Responses in Colitis Through Suppression of NLRP3 Inflammasome in Macrophage by AMPK/Sirt1 Dependent Signaling.
Pu Z; Liu Y; Li C; Xu M; Xie H; Zhao J
Am J Chin Med; 2020; 48(7):1693-1713. PubMed ID: 33202149
[TBL] [Abstract][Full Text] [Related]
17. The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse Model.
Chiu HW; Wu CH; Lin WY; Wong WT; Tsai WC; Hsu HT; Ho CL; Cheng SM; Cheng CC; Yang SP; Li LH; Hua KF
Inflammation; 2024 Apr; 47(2):696-717. PubMed ID: 38319541
[TBL] [Abstract][Full Text] [Related]
18. Libertellenone M, a diterpene derived from an endophytic fungus Phomopsis sp. S12, protects against DSS-induced colitis via inhibiting both nuclear translocation of NF-κB and NLRP3 inflammasome activation.
Fan M; Xiang G; Chen J; Gao J; Xue W; Wang Y; Li W; Zhou L; Jiao R; Shen Y; Xu Q
Int Immunopharmacol; 2020 Mar; 80():106144. PubMed ID: 31927507
[TBL] [Abstract][Full Text] [Related]
19. Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages.
Ke P; Shao BZ; Xu ZQ; Wei W; Han BZ; Chen XW; Su DF; Liu C
PLoS One; 2016; 11(9):e0155076. PubMed ID: 27611972
[TBL] [Abstract][Full Text] [Related]
20. Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation.
Ou Y; Yang Z; Zhou Y; Yue H; Hua L; Liu Z; Lin G; Cai H; Chen Y; Hu W; Sun P
Eur J Pharmacol; 2024 Feb; 965():176331. PubMed ID: 38220140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
